L-Arginine and allopurinol protect against cyclosporine nephrotoxicity

Transplantation

Volumn 63, Issue 8, 1997, Pages 1070-1073

  Assis, Sônia M A ^a,b   Monteiro, José L ^a   Seguro, Antonio C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ARGININE; CYCLOSPORIN; INULIN; NITRATE; NITRITE; OXYGEN RADICAL; XANTHINE OXIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; INULIN CLEARANCE; LIPID PEROXIDATION; MALE; NEPHROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; VASODILATATION;

EID: 0030975237     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199704270-00004     Document Type: Article

References (38)

1. Gruber SA, Chang GLC, Canafax DM, Matas AJ. Immunosuppression in renal transplantation: I. Cyclosporine and azathioprine. Clin Transplant 1991; 5: 65.
2. Berg KJ, Forre O, Bjerkhoel F, et al. Side effects of cyclosporin A treatment in patients with rheumatoid arthritis. Kidney Int 1986; 29: 1180.
3. Bennett WM, Burdmann EA, Andoh TF, Houghton DC, Lindsley J, Elzinga LW. Nephrotoxicity of immunosuppressive drugs. Nephrol Dial Transplant 1994; 9: 141.
4. Barros EJG, Boim MA, Ajzen H, Ramos OL, Schor N. Glomerular hemodynamics and hormonal participation on cyclosporine nephrotoxicity. Kidney Int 1987; 32: 19.
5. Conger JD, Kim GE, Robinette JB. Effects of Ang II, ETA, and TxA2 receptor antagonists on cyclosporin A renal vasoconstriction. Am J Physiol 1994; 267: F443.
6. Murray BM, Paller MS, Ferris TF. Effect of cyclosporine administration on renal hemodynamics in conscious rats. Kidney Int 1985; 28: 767.
7. +. Circ Res 1994; 74: 477.
8. Skorecki KL, Rutledge WP, Schrier RW. Acute cyclosporine nephrotoxicity: prototype for a renal membrane signalling disorder. Kidney Int 1992; 42: 1.
9. Takeda M, Breyer MD, Noland TD, et al. Endothelin-1 receptor antagonist : effects on endothelin- and cyclosporine-treated mesangial cells. Kidney Int 1992; 42: 1713.
10. De Nicola L, Thomson SC, Wead LM, Brown MR, Gabbai FB. Arginine feeding modifies cyclosporine nephrotoxicity in rats. J Clin Invest 1993; 92: 1859.
11. Walder CE, Vane JR. The involvement of endothelium-derived relaxing factor in the regulation of renal cortical blood flow in the rat. Br J Pharmacol 1991; 102: 967.
12. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323: 27.
13. Girerd X, Hirsch AT, Cooke JP, Dzau VJ, Creager MA. L-Arginine augments endothelium-dependent vasodilatation in cholesterol rabbits. Circ Res 1990; 67: 1301.
14. Raij L. Nitric oxide and the kidney. Circulation 1993; 87 (suppl V): v26.
15. Perrella MA, Edell ES, Krowka MJ, Cortese DA, Burnett JC Jr. Endothelium-derived relaxing factor in pulmonary and renal circulations during hypoxia. Am J Physiol 1992; 263: R45.
16. Cross CE, Halliwell B, Borish ET, et al. Oxygen radicals and human disease: Davis Conference. Ann Intern Med 1987; 107: 526.
17. McCord JM. Oxygen-derived free radicals in post ischemic tissue injury. N Engl J Med 1985; 312: 159.
18. Diamond JR, Bonventre JV, Karnovsky MJ. A role for oxygen free radicals in aminoglycoside nephrosis. Kidney Int 1986; 29: 478.
19. Southard JH, Van Gulik TM, Ametani MS, et al. Important components of the UW solution. Transplantation 1990; 49: 251.
20. 15N]niträte in biological fluids. Anal Biochem 1982; 126: 131.
21. Conrad KP, Joffe GM, Smith RP, Chavez JE, Mosher MD. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J 1993; 7: 566.
22. Ashab I, Peer G, Blum M, et al. Oral administration of L-arginine and captopril in rats prevents chronic renal failure by nitric oxide production. Kidney Int 1995; 47: 1515.
23. Amore A, Gianoglio B, Ghigo D, et al. A possible role for nitric oxide in modulating the functional cyclosporine toxicity by arginine. Kidney Int 1995; 47: 1507.
24. Bloom ITM, Bentley FR, Spain DA, Garrison RN. An experimental study of altered nitric oxide metabolism as a mechanism of cyclosporin-induced renal vasoconstriction. Br J Surg 1995; 82: 195.
25. Heberer M, Jörgensen J, Mihatsch MJ, Marx A, Landmann J. Protective effect of allopurinol and superoxide dismutase in renal isografts in cyclosporin A-treated rats. Ren Fail 1991; 13: 233.
26. Kusumoto K, Morimoto T, Minor T, Uchino J, Isselhard W. Allopurinol effects in rat liver transplantation on recovery of energy metabolism and free radical-induced damage. Eur Surg Res 1995; 27: 285.
27. Chocair PR, Duley JA, Simmonds HA, Cameron JS. The importance of thiopurine methyltransferase activity for the use of azathioprine in transplant recipients. Transplantation 1992; 53: 1051.
28. Chocair P, Duley J, Simmonds HA, et al. Low-dose allopurinol plus azathioprine/cyclosporine/prednisolone, a novel immunosuppressive regimen. Lancet 1993; 342: 83.
29. Ricardo SD, Bertran JF, Ryan GB. Podocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinol. Exp Nephrol 1995; 3: 270.
30. Wang C, Salahudeen AK. Cyclosporine nephrotoxicity: attenuation by an antioxidant-inhibitor of lipid peroxidation in vitro and in vivo. Transplantation 1994; 58: 940.
31. Shah BV, Hong CD, First MR. Effect of cyclosporine on fractional excretion of sodium in renal transplant patients. Clin Transplant 1990; 4: 10207.
32. Burdmann EA, Andoh TF, Rosen S, et al. Experimental nephrotoxicity, hepatotoxicity and pharmacokinetics of cyclosporin G versus cyclosporin A. Kidney Int 1994; 45: 684.
33. Dieperink H, Leyssac PP, Kemp E, Steinbruckl D, Starklint H. Glomerulotubular function in cyclosporin A-treated rats. Clin Nephrol 1986; 25: S70.
34. +-ATPase activity by cyclosporin A. Kidney Int 1993; 43: 246.
35. Battle DC, Gutterman C, Tarka J, Prasad R. Effect of short-term of cyclosporine A administration on urinary acidification. Clin Nephrol 1986; 25: S62.
36. Su Q, Weber L, Le Hir M, Zenke G, Ryffel B. Nephrotoxicity of cyclosporin A and FK 506: inhibition of calcineurin phosphatase. Renal Physiol Biochem 1995; 18: 128.
37. Hanas E, Tufveson G, Lindgren P-G, Sjöberg O, Tötterman TH. Concentrations of cyclosporine-A and its metabolites in transplanted human kidney tissue during rejection and stable graft function. Clin Transplant 1991; 5: 107.
38. Grevel J. Optimisation of immunosuppressive therapy using pharmacokinetic principles. Clin Pharmacokinet 1992; 23: 380.